List view / Grid view
Filter the results
Nemera is a world leader in the design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology and generics industries. Nemera always puts patients first, providing high-quality solutions that have a demonstrable impact on patients’ health, including off-the-shelf innovative systems, customized design development and GMP contract manufacturing.
A drug capsule that can carry insulin and protect them from the harsh environment of the gastrointestinal tract has been developed.
New chemical entities are largely insoluble, which creates a significant challenge when formulating new drugs; but scientists have recognised the potential of metal organic frameworks (MOFs) as alternative delivery mechanisms for such drugs.
Researchers have developed a series of lipid nanoparticles, which encapsulate RNA, for effective and improved vaccine delivery.
Increasing demand for convenient drug delivery, as well as an increase in diseases such as diabetes, has fuelled the global injectable drug delivery market.
With the approval of the treatment, Rybelsus, there is a new option for treating type 2 diabetes without injections.
A treatment for anaemia associated with chronic kidney disease in dialysis patients has been approved in Japan.
New vaccine patch has showed no negative side effects and could lead to a replacement of needle-based vaccination methods.
CPhI Worldwide will return for its 30th year on 5-7 November 2019 at Messe Frankfurt in Frankfurt, Germany.
GVOKE injection has received regulatory approval from the FDA for the treatment of severe hypoglycemia in patients with diabetes.
Bacteriostatic Water is being recalled because of a lack of sterilisation confirmation for some vials.
A team has developed a microrobot that is effective at targeting specific areas, so could be used in hyperthermia therapies when treating cancers.
New nanocapsules are a promising platform for many types of gene therapies due to their small size and superior stability.
A new study on DOX as a model drug has potential applications in the drug delivery field for better control drug release.